Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Nasus Pharma Ltd., Common Stock

NSRX

ASQ

$8.15

-$0.35

(-4.12%)

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$77.01M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

89.83K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$1 L

$9.51 H

$8.15

About Nasus Pharma Ltd., Common Stock

Nasus Pharma Ltd. operates as a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. The company offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel. more

Returns

Data is not properly formatted.

Time Frame	NSRX		S&P500
1-Week Return	0.62%%	%	-1.23%%
1-Month Return	-1.21%%	%	1.09%%

Financials

	Dec '22	Dec '23	Dec '24
Total Revenue	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	2.04M	1.15M	1.08M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":56.17,"profit":true},{"date":"2024-12-31","value":52.79,"profit":true}]
Operating Income	(2.04M)	(1.15M)	(1.08M)	[{"date":"2022-12-31","value":-204200000,"profit":false},{"date":"2023-12-31","value":-114700000,"profit":false},{"date":"2024-12-31","value":-107800000,"profit":false}]
Total Non-Operating Income/Expense	(110.00K)	142.00K	(474.00K)	[{"date":"2022-12-31","value":-77.46,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-333.8,"profit":false}]
Pre-Tax Income	(2.15M)	(1.00M)	(1.55M)	[{"date":"2022-12-31","value":-215200000,"profit":false},{"date":"2023-12-31","value":-100500000,"profit":false},{"date":"2024-12-31","value":-155200000,"profit":false}]
Income Taxes	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	(2.15M)	(1.00M)	(1.55M)	[{"date":"2022-12-31","value":-215200000,"profit":false},{"date":"2023-12-31","value":-100500000,"profit":false},{"date":"2024-12-31","value":-155200000,"profit":false}]
Income From Discontinued Operations	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(1.71M)	(1.05M)	(1.53M)	[{"date":"2022-12-31","value":-171100000,"profit":false},{"date":"2023-12-31","value":-105100000,"profit":false},{"date":"2024-12-31","value":-153200000,"profit":false}]

EPS (Diluted)	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

	Dec '22	Dec '23	Dec '24
Total Revenue	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	(43.83%)	(6.02%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Operating Income	-	(43.83%)	(6.02%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Total Non-Operating Income/Expense	-	(229.09%)	(433.80%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Pre-Tax Income	-	(53.30%)	54.43%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-97.93,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(53.30%)	54.43%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-97.93,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	(38.57%)	45.77%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-84.29,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]

	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	417.00K	444.00K	457.00K	[{"date":"2022-12-31","value":91.25,"profit":true},{"date":"2023-12-31","value":97.16,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	-	-	260.00K	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	417.00K	444.00K	717.00K	[{"date":"2022-12-31","value":58.16,"profit":true},{"date":"2023-12-31","value":61.92,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	3.20M	4.24M	3.93M	[{"date":"2022-12-31","value":75.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":92.64,"profit":true}]
Non-current Liabilities	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Liabilities	3.20M	4.24M	3.93M	[{"date":"2022-12-31","value":75.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":92.64,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	(10.08M)	(11.13M)	(12.66M)	[{"date":"2022-12-31","value":-1008100000,"profit":false},{"date":"2023-12-31","value":-1113200000,"profit":false},{"date":"2024-12-31","value":-1266400000,"profit":false}]
Other Stockholders' Equity	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	(2.79M)	(3.80M)	(3.21M)	[{"date":"2022-12-31","value":-278500000,"profit":false},{"date":"2023-12-31","value":-379700000,"profit":false},{"date":"2024-12-31","value":-321200000,"profit":false}]

Total Liabilities & Shareholders Equity	417.00K	444.00K	717.00K	[{"date":"2022-12-31","value":58.16,"profit":true},{"date":"2023-12-31","value":61.92,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	-	6.47%	2.93%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":45.22,"profit":true}]
Non-current Assets	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Assets	-	6.47%	61.49%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":10.53,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	32.45%	(7.36%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-22.67,"profit":false}]
Non-current Liabilities	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Liabilities	-	32.45%	(7.36%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-22.67,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	-	10.43%	13.76%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":75.76,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	36.34%	(15.41%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-42.4,"profit":false}]

Total Liabilities & Shareholders Equity	-	6.47%	61.49%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":10.53,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '23	Jun '24	Dec '24
Total Assets
Current Assets	444.00K	929.00K	457.00K	[{"date":"2023-12-31","value":47.79,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-12-31","value":49.19,"profit":true}]
Non-current Assets	-	91.00K	260.00K	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":35,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	444.00K	1.02M	717.00K	[{"date":"2023-12-31","value":43.53,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-12-31","value":70.29,"profit":true}]

Total Liabilities
Current Liabilities	4.24M	5.68M	3.93M	[{"date":"2023-12-31","value":74.63,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-12-31","value":69.14,"profit":true}]
Non-current Liabilities	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Liabilities	4.24M	5.68M	3.93M	[{"date":"2023-12-31","value":74.63,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-12-31","value":69.14,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	(11.13M)	(12.00M)	(12.66M)	[{"date":"2023-12-31","value":-1113200000,"profit":false},{"date":"2024-06-30","value":-1200300000,"profit":false},{"date":"2024-12-31","value":-1266400000,"profit":false}]
Other Stockholders' Equity	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	(3.80M)	(4.66M)	(3.21M)	[{"date":"2023-12-31","value":-379700000,"profit":false},{"date":"2024-06-30","value":-466300000,"profit":false},{"date":"2024-12-31","value":-321200000,"profit":false}]

Total Liabilities & Shareholders Equity	444.00K	1.02M	717.00K	[{"date":"2023-12-31","value":43.53,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-12-31","value":70.29,"profit":true}]

	Dec '23	Jun '24	Dec '24
Total Assets
Current Assets	-	109.23%	(50.81%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-12-31","value":-46.51,"profit":false}]
Non-current Assets	-	-	185.71%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	-	129.73%	(29.71%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-12-31","value":-22.9,"profit":false}]

Total Liabilities
Current Liabilities	-	34.00%	(30.86%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-12-31","value":-90.77,"profit":false}]
Non-current Liabilities	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Liabilities	-	34.00%	(30.86%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-12-31","value":-90.77,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	-	7.82%	5.51%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-12-31","value":70.38,"profit":true}]
Other Stockholders' Equity	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	22.81%	(31.12%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-12-31","value":-136.43,"profit":false}]

Total Liabilities & Shareholders Equity	-	129.73%	(29.71%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-12-31","value":-22.9,"profit":false}]

	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	(1.21M)	(1.03M)	(665.00K)	[{"date":"2022-12-31","value":-121100000,"profit":false},{"date":"2023-12-31","value":-102900000,"profit":false},{"date":"2024-12-31","value":-66500000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	1.47M	1.05M	770.00K	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":71.82,"profit":true},{"date":"2024-12-31","value":52.42,"profit":true}]

Net Change in Cash	(143.00K)	39.00K	101.00K	[{"date":"2022-12-31","value":-141.58,"profit":false},{"date":"2023-12-31","value":38.61,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(1.21M)	(1.03M)	(665.00K)	[{"date":"2022-12-31","value":-121100000,"profit":false},{"date":"2023-12-31","value":-102900000,"profit":false},{"date":"2024-12-31","value":-66500000,"profit":false}]

	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	-	(15.03%)	(35.37%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(28.18%)	(27.01%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Net Change in Cash	-	(127.27%)	158.97%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-80.06,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	(15.03%)	(35.37%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	NSRX
Current Ratio	0.12

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	NSRX
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	NSRX
Debt Ratio Lower is generally better. Negative is bad.	5.48
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-4.48

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	NSRX
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Nasus Pharma Ltd. share price today?

Nasus Pharma Ltd. (NSRX) share price today is $8.15

Can Indians buy Nasus Pharma Ltd. shares?

Yes, Indians can buy shares of Nasus Pharma Ltd. (NSRX) on Vested. To buy Nasus Pharma Ltd. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NSRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Nasus Pharma Ltd. be purchased?

Yes, you can purchase fractional shares of Nasus Pharma Ltd. (NSRX) via the Vested app. You can start investing in Nasus Pharma Ltd. (NSRX) with a minimum investment of $1.

How to invest in Nasus Pharma Ltd. shares from India?

You can invest in shares of Nasus Pharma Ltd. (NSRX) via Vested in three simple steps:

Click on Sign Up or Invest in NSRX stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Nasus Pharma Ltd. shares

What is Nasus Pharma Ltd. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Nasus Pharma Ltd. (NSRX) is 0.00

What is the Market Cap of Nasus Pharma Ltd.?

The market capitalization of Nasus Pharma Ltd. (NSRX) is $77.01M

What is Nasus Pharma Ltd.’s stock symbol?

The stock symbol (or ticker) of Nasus Pharma Ltd. is NSRX

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets Private Beta

Managed Portfolios (Previously Vests)

Global Mutual Funds Join Waitlist

Global

India

Explore our India Diversification

INR Bonds

Alt FDs

Nasus Pharma Ltd., Common Stock

NSRX

ASQ

$8.15

-$0.35

(-4.12%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About Nasus Pharma Ltd., Common Stock

Returns

Financials

Ratios

Liquidity

Asset Efficiency

Liabilities

Valuation

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²